Article info
Electronic pages
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen
- Dr P Lindgren, i3innovus, Vasagatan 38, 11120 Stockholm, Sweden; peter.lindgren{at}healtheconomics.se
Citation
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen
Publication history
- Accepted August 7, 2007
- First published October 4, 2007.
Online issue publication
January 14, 2008
Article Versions
- Previous version (4 October 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and British Cardiovascular Society